Results 11 to 20 of about 1,494,677 (294)
BMC Women's Health, 2004 HEALTH ISSUE: Cardiovascular disease (CVD) is the leading cause of death in Canadian women and men. In general, women present with a wider range of symptoms, are more likely to delay seeking medial care and are less likely to be investigated and treated with evidence-based medications, angioplasty or coronary artery bypass graft than men. KEY FINDINGS:
Grace, Sherry L +3 more
openaire +5 more sources
Exercise and cardiovascular diseases [PDF]
Acta Physiologica, 2014 Exercise is a physiologic stressor that has multiple beneficial effects on cardiovascular system. Currently exercise training is a class I intervention as part of a multifactorial long-term process that includes: clinical assistance, assessment of global cardiovascular risk, identification of specific objective for each cardiovascular risk factor ...
Philipp Hillmeister +4 more
openaire +7 more sources
Hyperuricemia is associated with metabolic syndrome in the community very elderly in Chengdu
Scientific Reports, 2020 Hyperuricemia is a risk factor for cardiovascular metabolic diseases. However, in the very elderly, the relationship between hyperuricemia and the metabolic syndrome (MetS) is not yet clear.
Gang Huang +6 more
doaj +1 more source
Investigation of the Effects of Some Cardiovascular Drugs on Angiogenesis by Transgenic Zebrafish
Mediators of Inflammation, 2023 Introduction. Angiogenesis contributes to the pathophysiology of cardiovascular disease (CVD). Some cardiovascular drugs used in the treatment of CVD have an effect on the process of angiogenesis. Methods.
Hui Lv, Bo Liu, Yongwen Qin
doaj +1 more source
Luteolin Pretreatment Ameliorates Myocardial Ischemia/Reperfusion Injury by lncRNA-JPX/miR-146b Axis
Analytical Cellular Pathology, 2023 Background. In the present study, we aimed to find out whether luteolin (Lut) pretreatment could ameliorate myocardial ischemia/reperfusion (I/R) injury by regulating the lncRNA just proximal to XIST (JPX)/microRNA-146b (miR-146b) axis. Methods.
Tongda Xu +7 more
doaj +1 more source
Mitophagy in Cardiovascular Diseases [PDF]
Journal of Clinical Medicine, 2020 Cardiovascular diseases are one of the leading causes of death. Increasing evidence has shown that pharmacological or genetic targeting of mitochondria can ameliorate each stage of these pathologies, which are strongly associated with mitochondrial dysfunction.
Morciano, Giampaolo +11 more
openaire +4 more sources
Frontiers in Physiology, 2018 Background: Lysophosphatidic acid (LPA), as a phospholipid signal molecule, participates in the regulation of various biological functions. Our previous study demonstrated that LPA induces cardiomyocyte hypertrophy in vitro; however, the functional role ...
Jinjing Yang +15 more
doaj +1 more source
Orthostatic variation of pulmonary artery pressure in ambulatory heart failure patients
BMC Cardiovascular Disorders, 2023 Aim To study effect of change in position (supine and standing) on pulmonary artery pressure (PAP) in ambulatory heart failure (HF) patients. Methods Seventeen patients with CardioMEMS® sensor and stable heart failure were consented and included in this ...
Prince Sethi +8 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020 Background After the coronavirus disease 2019 outbreak, social isolation measures were introduced to contain infection. Although there is currently a slowing down of the infection, a reduction of hospitalizations, especially for myocardial infarction ...
Valeria Cammalleri +15 more
doaj +1 more source
CONNECTIONS BETWEEN PERIODONTAL DISEASE AND CARDIOVASCULAR DISEASE
Romanian Journal of Oral Rehabilitation, 2023 Cardiovascular disease and periodontal disease are two distinct conditions that have been found to be linked through various research studies. Periodontal disease is a chronic inflammatory condition that affects the supporting structures of the teeth ...
Ion Andrei Hurjui +10 more
doaj